Table 1.
Demographics.
| CT + definitive RT (N = 11) | CT + palliative RT (N = 8) |
CT only (N = 10) |
p-value | |
|---|---|---|---|---|
| Age median (range) | 44.8 (35–67) | 51.2 (37–66) | 45.8 (31–71) | 0.40 |
| Race N(%) | ||||
| Non-white | 0 (0%) | 3 (37.5%) | 1 (10.0%) | 0.049 |
| White | 11 (100%) | 5 (62.5%) | 9 (90.0%) | |
| BMI (mean ± SD) | 31.1 ± 8.8 | 36.6 ± 11.2 | 31.1 ± 10.5 | 0.39 |
|
Any comorbidity N (%) |
||||
| No | 7 (63.6%) | 4 (50%) | 4 (40.0%) | 0.58 |
| Yes | 4 (36.4%) | 4 (50%) | 6 (60.0%) | |
| Histology N(%) | ||||
| Squamous cell | 10 (90.9%) | 6 (75.0%) | 7 (70.0%) | 0.78 |
| Adenocarcinoma | 0 | 1 (12.5%) | 3 (30.0%) | |
| Adenosquamous | 1 (9.1%) | 1 (12.5%) | 0 | |
| Grade N(%) | ||||
| Grade 2 | 2 (18.2%) | 2 (25.0%) | 3 (30.0%) | 0.96 |
| Grade 3 | 6 (54.5%) | 5 (62.5%) | 7 (70.0%) | |
| Unknown | 3 (27.3%) | 1 (12.5%) | 0 | |
| GOG Performance status N (%) | ||||
| 0 | 4 (36.3%) | 5 (62.5%) | 6 (60.0%) | 0.31 |
| 1 | 7 (63.7%) | 2 (25.0%) | 4 (40.0%) | |
| 2 | 0 | 1 (12.5%) | 0 | |
| Hydronephrosis | 1.00 | |||
| No | 7 (63.7%) | 6 (75.0%) | 7 (70.0%) | |
| Yes | 4 (36.3%) | 2 (25.0%) | 3 (30.0%) | |
| Number metastases | ||||
| 1 | 1 (9.1%) | 0 | 2 (20.0%) | 0.56 |
| 2–5 | 2 (18.2%) | 1 (12.5%) | 1 (10.0%) | |
| 6+ | 8 (72.7%) | 7 (87.5%) | 7 (70.0%) | |
| CT cycles (mean) | 6.7 (3–9) | 7.8 (6–12) | 8.4 (6–9) | 0.23 |
Legend: BMI – body mass index, CT – chemotherapy, RT – radiation therapy.